...
首页> 外文期刊>The Journal of arthroplasty >Minimally invasive total hip arthroplasty: in opposition.
【24h】

Minimally invasive total hip arthroplasty: in opposition.

机译:微创全髋关节置换术:相反。

获取原文
获取原文并翻译 | 示例
           

摘要

At the Knee Society Winter Meeting in 2003, Seth Greenwald and I debated about whether there should be new standards (ie, regulations) applied to the release of information to the public on "new developments." I argued for the public's "right to know" prior to the publication of peer-reviewed literature. He argued for regulatory constraint or "proving by peer-reviewed publication" before alerting the public. It is not a contradiction for me to currently argue against the public advertising of minimally invasive (MIS) total hip arthroplasty as not yet being in the best interest of the public. It is hard to remember a concept that has so captured both the public's and the surgical community's fancy as MIS. Patients are "demanding" MIS without knowing why. Surgeons are offering it as the next best, greatest thing without having developed the skill and experience to avoid the surgery's risks. If you put "minimally invasive hip replacement" into the Google search engine (http://www.google.com), you get 5,170 matches. If you put the same words in PubMed (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi), referencing the National Library of Medicine database, you get SEVENTEEN; none is really a peer-reviewed article. Most are 1 page papers in orthopedics from medical education meetings. On the other hand, there are over 6,000 peer-reviewed articles on total hip arthroplasty. Dr. Thomas Sculco, my couterpart in this debate, wrote an insightful editorial in the American Journal of Orthopedic Surgery in which he stated: "Although these procedures have generated incredible interest and enthusiasm, I am concerned that they may be performed to the detriment of our patients." I couldn't agree with him more. Smaller is not necessarily better and, when it is worse, it will be the "smaller" that is held accountable.
机译:在2003年的膝盖学会冬季会议上,我和塞思·格林瓦尔德(Seth Greenwald)辩论了是否应采用新标准(即法规)来向公众发布有关“新发展”的信息。在发表经同行评审的文献之前,我主张公众具有“知情权”。他在警告公众之前主张监管限制或“由同行评审的出版物证明”。对于我而言,目前不反对微创(MIS)全髋关节置换术的公共广告尚未成为公众的最大利益,这与我并不矛盾。很难记住这样一个概念,它已经吸引了公众和外科界对MIS的喜爱。患者在不知为何的情况下“要求” MIS。外科医生在没有发展出避免手术风险的技能和经验的情况下,将其作为次要的,最大的事情。如果将“微创髋关节置换术”放入Google搜索引擎(http://www.google.com),则会获得5,170个匹配项。如果将相同的词放在PubMed(http://www.ncbi.nlm.nih.gov/entrez/query.fcgi)中,并引用国家医学图书馆数据库,则会得到SEVENTEEN;没有什么是真正的同行评审文章。大多数是医学教育会议上关于整形外科的1页论文。另一方面,关于全髋关节置换术的同行评审文章超过6,000篇。我在这场辩论中的佼佼者托马斯·斯库尔科(Thomas Sculco)博士在《美国整形外科杂志》上发表了一篇有见地的社论,他说:“尽管这些程序引起了人们极大的兴趣和热情,但我担心这些程序的执行可能会损害我们的病人。”我完全同意他的看法。较小不一定意味着更好,而当情况变得更糟时,将追究“较小”的责任。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号